ARCHIVES

Degarelix Active In Phase II Trial In Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 27 No. 10 | October 29, 2004

Download PDF Visit The Full Archive

Related Articles

Phase III BETH Study Combining Avastin And Herceptin Open For Enrollment

June 27, 2008

In Brief NCI-FDA Relations Tops, DeVita Says; Upon Talks to Candidates For Prospective Division

November 24, 1978

New Subcontracts Planned In Bioassay Program Run by Traco-JITCO

May 23, 1975

FDA Approval Of Two Generic Versions Of Taxol Likely To End BMS Exclusivity.

September 29, 2000

NIH to ban consulting by top officials, limit outside work by other employees.

June 25, 2004

St. Jude Children’s Research Hospital Wins NCI Designation As Comprehensive.

May 16, 2008